Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNPH1 | O43598 | 4/20 | 1.00 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.86 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.86 |
| ▸ | NT5E | P21589 | 5/20 | 0.84 |
| ▸ | ADORA3 | P0DMS8 | 7/20 | 0.74 |
| ▸ | TP53 | P04637 | 1/20 | 0.74 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.74 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.73 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.67 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.67 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL218999 | 1.00 | DNPH1 (1.00) | DNPH1P2RX3P2RX2NT5EADORA3 | |
| SCHEMBL13957724 | 1.00 | DNPH1 (1.00) | DNPH1P2RX3P2RX2NT5EADORA3 | |
| SCHEMBL17022278 | 1.00 | DNPH1 (1.00) | DNPH1P2RX3P2RX2NT5EADORA3 | |
| SCHEMBL14700471 | 1.00 | DNPH1 (1.00) | DNPH1P2RX3P2RX2NT5EADORA3 | |
| SCHEMBL13972003 | 1.00 | DNPH1 (1.00) | DNPH1P2RX3P2RX2NT5EADORA3 | |
| SCHEMBL23440101 | 1.00 | DNPH1 (1.00) | DNPH1P2RX3P2RX2NT5EADORA3 | |
| SCHEMBL9607782 | 0.93 | P2RX3 (0.98) | DNPH1P2RX3P2RX2NT5EADORA3 | |
| SCHEMBL30076630 | 0.93 | P2RX3 (0.98) | DNPH1P2RX3P2RX2NT5EADORA3 | |
| SCHEMBL29941330 | 0.93 | P2RX3 (0.98) | DNPH1P2RX3P2RX2NT5EADORA3 | |
| SCHEMBL13033867 | 0.93 | P2RX3 (0.98) | DNPH1P2RX3P2RX2NT5EADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230417751-A1 | ANALYSIS OF PROTEIN KINASES IN LIVE CELLS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2023-12-28 | — | — | US | claimed |
| US-20250197513-A1 | OSMR-SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-06-19 | — | — | US | disclosed |
| US-12201075-B2 | Methods and compositions for axillary shoot micropropagation of Cannabis and related plants | JUSHI IP, LLC (US) | 2025-01-21 | — | — | US | disclosed |
| EP-4377356-A1 | OSMR-SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-06-05 | — | — | EP | disclosed |
| CN-117916265-A | OSMR-specific monoclonal antibodies and methods of use thereof | 德克萨斯大学系统董事会 | 2024-04-19 | — | — | CN | disclosed |
| WO-2023010093-A9 | OSMR-SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-01-25 | — | — | WO | disclosed |
| US-20230417751-A1 | ANALYSIS OF PROTEIN KINASES IN LIVE CELLS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2023-12-28 | — | — | US | disclosed |
| EP-4228397-A1 | METHODS AND COMPOSITIONS FOR AXILLARY SHOOT MICROPROPAGATION OF CANNABIS AND RELATED PLANTS | Phytotech Labs, Inc. (US) | 2023-08-23 | — | — | EP | disclosed |
| WO-2023010093-A1 | OSMR-SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-02-02 | — | — | WO | disclosed |
| US-20220323444-A1 | Methods of Treating Advanced Prostate Cancer | THE MEDICAL COLLEGE OF WISCONSIN, INC. | 2022-10-13 | — | — | US | disclosed |
| WO-2022081767-A1 | METHODS AND COMPOSITIONS FOR AXILLARY SHOOT MICROPROPAGATION OF CANNABIS AND RELATED PLANTS | PHYTOTECH LABS, INC. (US) | 2022-04-21 | — | — | WO | disclosed |
| US-20220110278-A1 | METHODS AND COMPOSITIONS FOR AXILLARY SHOOT MICROPROPAGATION OF CANNABIS AND RELATED PLANTS | JUSHI IP, LLC | 2022-04-14 | — | — | US | disclosed |